Aug. 24 at 6:15 PM
$ABCL
$ABCL
- The Thesis:
Insider buying doesn't guarantee market-beating returns, but economic theory backs it as a strong signal for future performance.
Nuance matters though — in banking, for example, CFO purchases historically outperform CEO purchases, which in turn outperform the market.
For me, insiders carry immense informational value — especially in complex, technical sectors like biotech.
With
$ABCL
, I understood the thesis on paper. But understanding a thesis and pulling the trigger are two different things.
That's where the insiders stepped in. I don't think I've seen conviction this widespread across every level of an organization before.
We started accumulating around
$3/share and kept adding over time.
